CPRX
Catalyst Pharmaceuticals
Stock NASDAQ – Stock Market Prices, News & Analysis
Catalyst Pharmaceuticals Inc développe et commercialise des médicaments pour le traitement de maladies neurologiques rares et compliquées, notamment la myasthénie grave.
$ 23.23
0.68 %
Catalyst Pharmaceuticals
$
23.23
0.68 %
CPRX
Catalyst Pharmaceuticals Inc développe et commercialise des médicaments pour le traitement de maladies neurologiques rares et compliquées, notamment la myasthénie grave.
Price history of Catalyst Pharmaceuticals
Price history of Catalyst Pharmaceuticals
Performance & Momentum
6 Months
22.57 %
1 Year
18.60 %
3 Years
62.89 %
5 Years
530.21 %
Momentum
79
Similar stocks to Catalyst Pharmaceuticals
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
